Literature DB >> 17764731

Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse.

Lionel Moulédous1, Miguel F Díaz, Howard B Gutstein.   

Abstract

The clinical use of opioids is limited by the development of tolerance and physical dependence. Opioid tolerance and dependence are believed to result from complex adaptations in the CNS, representing a form of neural plasticity. Extracellular signal-regulated kinases (ERKs) are involved in many forms of neural plasticity, and therefore could also be involved in the development of opioid tolerance and dependence. In this study, we investigated the effect of a systemically bioavailable MEK (ERK kinase) inhibitor, SL327, upon the development and the expression of tolerance to and dependence on morphine in mice. In tolerance and dependence development studies, two strains of mice were treated daily for 8 or 9 days with 5mg/kg morphine s.c. Tolerance development was assessed by tail flick latency. Withdrawal was then precipitated by subcutaneous injection of 2mg/kg naloxone s.c. and signs recorded. Co-administration of 50mg/kg SL327 i.p. prior to morphine administration had no effect on the development of tolerance or withdrawal signs. To study possible effects of ERK inhibition on the expression of tolerance and dependence, mice were implanted with 75mg morphine pellets s.c. Tolerance and dependence were assessed as previously described. An acute i.p. injection of 50mg/kg SL327 after 4 days of morphine exposure had no effect on the expression of either morphine tolerance or physical dependence. To verify that this dose of SL327 inhibited morphine-induced ERK modulation, mice received an acute i.p. injection of 50mg/kg SL327 prior to morphine administration, and sacrificed 30min later. Western blots demonstrated that SL327 did inhibit morphine-induced ERK modulation. Taken together, these data suggest that unlike many other observed forms of neural plasticity, the ERK signaling cascade is not involved in the development or expression of opioid tolerance and dependence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764731      PMCID: PMC2151045          DOI: 10.1016/j.pbb.2007.07.002

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  33 in total

Review 1.  Cellular and synaptic adaptations mediating opioid dependence.

Authors:  J T Williams; M J Christie; O Manzoni
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

Review 2.  Molecular mechanisms and regulation of opioid receptor signaling.

Authors:  P Y Law; Y H Wong; H H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

3.  A necessity for MAP kinase activation in mammalian spatial learning.

Authors:  J C Selcher; C M Atkins; J M Trzaskos; R Paylor; J D Sweatt
Journal:  Learn Mem       Date:  1999 Sep-Oct       Impact factor: 2.460

Review 4.  Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain.

Authors:  R R Ji; C J Woolf
Journal:  Neurobiol Dis       Date:  2001-02       Impact factor: 5.996

5.  Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties.

Authors:  E Valjent; J C Corvol; C Pages; M J Besson; R Maldonado; J Caboche
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

6.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 7.  The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory.

Authors:  J D Sweatt
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

8.  Opioid receptor endocytosis and activation of MAP kinase pathway.

Authors:  N Trapaidze; I Gomes; S Cvejic; M Bansinath; L A Devi
Journal:  Brain Res Mol Brain Res       Date:  2000-03-29

9.  Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference.

Authors:  Emmanuel Valjent; Anne-Gaëlle Corbillé; Jesus Bertran-Gonzalez; Denis Hervé; Jean-Antoine Girault
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

Review 10.  Ras-related and MAPK signalling in neuronal plasticity and memory formation.

Authors:  C Mazzucchelli; R Brambilla
Journal:  Cell Mol Life Sci       Date:  2000-04       Impact factor: 9.261

View more
  13 in total

Review 1.  Opioid receptor trafficking and signaling: what happens after opioid receptor activation?

Authors:  Jia-Ming Bian; Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2011-09-25       Impact factor: 5.046

2.  Inhibition of extracellular signal-regulated kinase (ERK) activity with SL327 does not prevent acquisition, expression, and extinction of ethanol-seeking behavior in mice.

Authors:  Peter A Groblewski; Frederick H Franken; Christopher L Cunningham
Journal:  Behav Brain Res       Date:  2010-11-11       Impact factor: 3.332

Review 3.  The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence.

Authors:  Yong Chen; Claudia Sommer
Journal:  Mol Neurobiol       Date:  2009-05-26       Impact factor: 5.590

4.  Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat.

Authors:  Tara A Macey; Erin N Bobeck; Deborah M Hegarty; Sue A Aicher; Susan L Ingram; Michael M Morgan
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

5.  Differential central NOS-NO signaling underlies clonidine exacerbation of ethanol-evoked behavioral impairment.

Authors:  Tara S Bender; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2009-12-17       Impact factor: 3.455

6.  Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain.

Authors:  Wei Lei; Nathan Mullen; Sarah McCarthy; Courtney Brann; Philomena Richard; James Cormier; Katie Edwards; Edward J Bilsky; John M Streicher
Journal:  J Biol Chem       Date:  2017-04-27       Impact factor: 5.157

Review 7.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

8.  Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance.

Authors:  Erin N Bobeck; Susan L Ingram; Sam M Hermes; Sue A Aicher; Michael M Morgan
Journal:  Behav Brain Res       Date:  2015-10-20       Impact factor: 3.332

9.  Pre- and postsynaptic regulation of locus coeruleus neurons after chronic morphine treatment: a study of GIRK-knockout mice.

Authors:  Maria Torrecilla; Nidia Quillinan; John T Williams; Kevin Wickman
Journal:  Eur J Neurosci       Date:  2008-08       Impact factor: 3.386

10.  Alpha 2A-adrenergic receptor signaling underlies synergistic enhancement of ethanol-induced behavioral impairment by clonidine.

Authors:  Tara Summer Bender; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2008-12-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.